Literature DB >> 23966511

A convenient method to screen for carbapenemase-producing Pseudomonas aeruginosa.

Damien Fournier1, Pauline Garnier, Katy Jeannot, Amélie Mille, Anne-Sophie Gomez, Patrick Plésiat.   

Abstract

A combined-disk method using imipenem and cloxacillin was evaluated to discriminate between carbapenemase-producing (n = 56) and nonproducing (n = 62) strains of Pseudomonas aeruginosa. With a cloxacillin load of 4,000 μg/disk, this very simple method showed a sensitivity and a specificity of 100%, irrespective of the type of carbapenemase produced.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23966511      PMCID： PMC3889778          DOI： 10.1128/JCM.01299-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa.

Authors:  D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

3.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

4.  GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem.

Authors:  L Poirel; G F Weldhagen; T Naas; C De Champs; M G Dove; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

5.  Biochemical and structural characterization of the subclass B1 metallo-β-lactamase VIM-4.

Authors:  Patricia Lassaux; Daouda A K Traoré; Elodie Loisel; Adrien Favier; Jean-Denis Docquier; Jean Sébastien Sohier; Clémentine Laurent; Carine Bebrone; Jean-Marie Frère; Jean-Luc Ferrer; Moreno Galleni
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

6.  Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR.

Authors:  Jean-Luc Dumas; Christian van Delden; Karl Perron; Thilo Köhler
Journal:  FEMS Microbiol Lett       Date:  2006-01       Impact factor: 2.742

7.  Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction.

Authors:  Katy Jeannot; Mara L Sobel; Farid El Garch; Keith Poole; Patrick Plésiat
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

8.  Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Authors:  Damien Fournier; Charlotte Richardot; Emeline Müller; Marjorie Robert-Nicoud; Catherine Llanes; Patrick Plésiat; Katy Jeannot
Journal:  J Antimicrob Chemother       Date:  2013-04-14       Impact factor: 5.790

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates.

Authors:  Renata C Picão; Soraya S Andrade; Adriana Gianinni Nicoletti; Eloiza H Campana; Gabriela C Moraes; Rodrigo E Mendes; Ana C Gales
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948
View more
  9 in total

1.  A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.

Authors:  Agila Kumari Pragasam; Rani Diana Sahni; Shalini Anandan; Archa Sharma; Radha Gopi; Noorjahan Hadibasha; Priya Gunasekaran; Balaji Veeraraghavan
Journal:  J Clin Diagn Res       Date:  2016-07-01

2.  Evaluation of several phenotypic methods for the detection of carbapenemase-producing Pseudomonas aeruginosa.

Authors:  A Heinrichs; T D Huang; C Berhin; P Bogaerts; Y Glupczynski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-21       Impact factor: 3.267

3.  Dissemination of high-risk clones of extensively drug-resistant Pseudomonas aeruginosa in colombia.

Authors:  Adriana Correa; Rosa Del Campo; Marcela Perenguez; Victor M Blanco; Mercedes Rodríguez-Baños; Federico Perez; Juan J Maya; Laura Rojas; Rafael Cantón; Cesar A Arias; Maria V Villegas
Journal:  Antimicrob Agents Chemother       Date:  2015-01-20       Impact factor: 5.191

4.  Co-production of Classes A and B Carbapenemases BKC-1 and VIM-2 in a Clinical Pseudomonas Putida Group Isolate from Brazil.

Authors:  Amanda Yaeko Yamada; Andreia Rodrigues de Souza; Marisa de Jesus de Castro Lima; Alex Domingos Reis; Karoline Rodrigues Campos; Amanda Maria de Jesus Bertani; Leonardo Jose Tadeu de Araujo; Claudio Tavares Sacchi; Monique Ribeiro Tiba-Casas; Carlos Henrique Camargo
Journal:  Curr Microbiol       Date:  2022-07-14       Impact factor: 2.343

5.  Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.

Authors:  G Mikucionyte; L Zamorano; A Vitkauskiene; C López-Causapé; C Juan; X Mulet; A Oliver
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-05       Impact factor: 3.267

6.  Resistance of Animal Strains of Pseudomonas aeruginosa to Carbapenems.

Authors:  Marisa Haenni; Maxime Bour; Pierre Châtre; Jean-Yves Madec; Patrick Plésiat; Katy Jeannot
Journal:  Front Microbiol       Date:  2017-09-29       Impact factor: 5.640

7.  Pseudomonas aeruginosa in Dairy Goats: Genotypic and Phenotypic Comparison of Intramammary and Environmental Isolates.

Authors:  Licia Scaccabarozzi; Livia Leoni; Annalisa Ballarini; Antonio Barberio; Clara Locatelli; Antonio Casula; Valerio Bronzo; Giuliano Pisoni; Olivier Jousson; Stefano Morandi; Luca Rapetti; Aurora García-Fernández; Paolo Moroni
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

8.  Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany.

Authors:  Elena Schäfer; Monika Malecki; Carlos J Tellez-Castillo; Niels Pfennigwerth; Lennart Marlinghaus; Paul G Higgins; Frauke Mattner; Andreas F Wendel
Journal:  Antimicrob Resist Infect Control       Date:  2019-12-30       Impact factor: 4.887

9.  In vitro Reducing Effect of Cloxacillin on Minimum Inhibitory Concentrations to Imipenem, Meropenem, Ceftazidime, and Cefepime in Carbapenem-resistant Pseudomonas aeruginosa Isolates.

Authors:  Farahnaz Pahlavanzadeh; Davood Kalantar-Neyestanaki; Mohammad Motamedifar; Shahla Mansouri
Journal:  Yale J Biol Med       Date:  2020-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.